Core Insights - Prysmian's Draka EHC has been awarded the title of Best Supplier for Ropes/Traveling Cables at the 2025 Elevator Industry (Ellie) Awards [1] - The company also secured the runner-up position for Best Supplier in Safety Products [1] - The Ellie Awards have been recognizing outstanding North American vertical-transportation businesses for the past eight years [1] Company Recognition - The awards were presented by Elevator World, highlighting the achievements of companies that excel in customer service, employee satisfaction, and community engagement [1] - Draka EHC's recognition reflects its commitment to quality and innovation in the elevator industry [1]

Core Insights - Encompass Health Corporation (EHC) has opened a new rehabilitation hospital in Lake Worth, Florida, expanding its presence in the state to 26 locations [2][5] - The new facility is equipped with 50 beds and aims to assist patients recovering from complex medical issues, including strokes and major surgeries [2][4] - EHC's approach emphasizes an interdisciplinary care model, providing tailored treatment plans to enhance patients' mobility and quality of life [4] Company Expansion - The Lake Worth facility features advanced rehabilitation technologies, private patient rooms, and comprehensive care services, including in-house dialysis and pharmacy [3][9] - EHC operates a total of 173 rehabilitation hospitals across 39 states and Puerto Rico, positioning itself for sustained growth in the post-acute care segment [5][6] - The company plans to open seven new hospitals and add approximately 127 beds to existing facilities in 2025 [6] Financial Performance - EHC's net operating revenues increased by 10.6% year over year in the first nine months of 2025 [6] - Year-to-date, EHC shares have gained 23.3%, outperforming the industry growth of 10.3% [7] Market Position - EHC currently holds a Zacks Rank of 3 (Hold), with several competitors in the medical space holding higher ranks [10] - The company is well-positioned to meet the rising demand for rehabilitation services as the U.S. population ages and chronic health conditions become more prevalent [4]

Accessibility StatementSkip Navigation BIRMINGHAM, Ala. and LAKE WORTH, Fla., Dec. 2, 2025 /PRNewswire/ --Â Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Lake Worth. The 50-bed inpatient rehabilitation hospital is now accepting patients. Encompass Health Rehabilitation Hospital of Lake Worth exterior The more than 55,000-square-foot, freestanding hospital provides essential rehabili ...

Core Insights - Encompass Health Corporation (EHC) has expanded its partnership with Vanderbilt Health to build a new 40-bed inpatient rehabilitation hospital in Lebanon, TN, expected to open in 2028 [1][5][9] Facility Details - The new hospital will feature private patient rooms, a large therapy gym with advanced rehabilitation technologies, daily living suite activities, an in-house dialysis unit, a pharmacy, and a therapy courtyard [2] - Specialized care will be provided for patients recovering from serious illnesses and injuries, including strokes, neurological disorders, traumatic brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions [3] Operational Impact - The facility aims to enhance patient recovery speed and improve health outcomes for residents in Wilson, Smith, Trousdale, and Macon counties [4] - EHC's expansion aligns with the increasing demand for inpatient rehabilitation services due to a rise in patients with serious health conditions [7] Financial Performance - In the first nine months of 2025, EHC reported revenues of $4.4 billion, reflecting a 10.6% increase compared to the same period in the previous year [6] - EHC's share price has increased by 13% over the past year, outperforming the industry average growth of 1.9% [8]

Core Points - Encompass Health Corp. and Vanderbilt Health are collaborating to build a 40-bed freestanding inpatient rehabilitation hospital in Lebanon, Tennessee, expected to open in 2028 [1][3][4] - The new facility aims to provide high-quality rehabilitation care for patients recovering from severe illnesses and injuries, including strokes and neurological disorders, with a focus on comprehensive rehabilitation services [2][4] - The hospital will feature private patient rooms, advanced rehabilitation technologies, and various therapy services, enhancing the existing acute care services in the region [3][4] Company Overview - Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with 172 hospitals across 39 states and Puerto Rico, recognized for its high-quality rehabilitative care [5] - The company has been awarded as America's Most Awarded Leader in Inpatient Rehabilitation and is ranked among Fortune's Most Admired Companies and Forbes' Most Trusted Companies [5]

Core Points - Encompass Health Corp. plans to build a 50-bed freestanding inpatient rehabilitation hospital in Fishers, Indiana, expected to open in 2027 [1][3] - The new facility will cater to patients recovering from various debilitating conditions, including strokes, brain injuries, and complex orthopedic conditions, providing specialized nursing and therapy services [2][3] - The hospital will feature private patient rooms, advanced rehabilitation technologies, and various amenities to enhance patient care and recovery [3] Company Overview - Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with 172 hospitals across 39 states and Puerto Rico [4] - The company is recognized for its high-quality rehabilitative care and has received accolades such as being named America's Most Awarded Leader in Inpatient Rehabilitation [4] - Encompass Health aims to expand its presence in Indiana to meet the growing demand for inpatient rehabilitation services [3][4]

Core Insights - Encompass Health Corporation (EHC) shares have declined by 8.3% following the release of its third-quarter 2025 results, primarily due to increased operating expenses, although strong net patient revenue and capacity expansion measures provided some offset [1][8] Financial Performance - EHC reported adjusted earnings per share (EPS) of $1.23 for Q3 2025, exceeding the Zacks Consensus Estimate by 3.4% and reflecting a year-over-year increase of 19.4% [2][8] - Net operating revenues rose by 9.4% year over year to $1.5 billion, slightly surpassing consensus estimates by 0.1% [2][3] - Net patient revenue per discharge increased by 3.3% year over year to $21.7 billion, outperforming the growth estimate of 2.7% [3][8] - Total operating expenses reached $1.2 billion, an increase of 8.1% year over year, driven by higher salaries and benefits [3][8] - Net income for the quarter was $174.6 million, up 18.7% year over year, while adjusted EBITDA improved by 11.4% to $300.1 million, exceeding estimates [4][8] Operational Highlights - EHC added 39 beds to existing hospitals and opened three de novo hospitals during the quarter [4][8] - Total discharges increased by 5% year over year to 65,839, although this fell short of consensus estimates [3][8] Financial Position - As of September 30, 2025, EHC had cash and cash equivalents of $48.7 million, down from $85.4 million at the end of 2024 [5][6] - Total assets increased by 5.1% to $6.9 billion, while long-term debt rose by 1.5% to $2.4 billion [5][6] - Shareholders' equity advanced by 12.1% to $3.1 billion, and net cash from operations was $270.8 million, a 1.1% increase year over year [6] Capital Deployment - EHC repurchased shares worth $24.9 million during the quarter and has approximately $408 million remaining under its buyback authorization [7][8] - The company declared a quarterly cash dividend of 19 cents per share [7] Future Outlook - EHC raised its 2025 revenue forecast to between $5.905 billion and $5.955 billion, indicating a 10.4% increase from 2024 [9][10] - Adjusted EBITDA for 2025 is now estimated to be between $1.235 billion and $1.255 billion, reflecting a 12.8% growth from 2024 [9][10] - The adjusted EPS outlook for 2025 has been revised to a range of $5.22 to $5.37, suggesting a 19.5% increase from the previous year [10] - The company aims to open seven de novo hospitals and add 340 beds in 2025, with a long-term goal of inaugurating six to ten de novos annually from 2023 to 2027 [11][12]

Core Insights - Encompass Health and BSA Health System have opened the Rehabilitation Hospital of Amarillo, a 50-bed inpatient rehabilitation facility aimed at enhancing access to rehabilitation services in the Texas Panhandle region [1][4]. Company Overview - Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with 172 hospitals across 39 states and Puerto Rico [5]. - BSA Health System is the largest healthcare employer in the Texas Panhandle, operating a comprehensive healthcare system that includes a flagship 445-bed hospital and various specialized centers [7]. Facility Details - The Rehabilitation Hospital of Amarillo spans over 54,000 square feet and provides rehabilitation services for patients recovering from strokes, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions [2]. - Patients will receive a minimum of three hours of intensive therapy five days a week, along with 24-hour nursing care and frequent physician visits [2]. Strategic Importance - The new hospital is expected to more than double the region's capacity for inpatient rehabilitation, providing a dedicated care destination close to home for local patients [4]. - The facility is designed with patient needs in mind, featuring private rooms, advanced rehabilitation technologies, and various amenities to support recovery [3].

Financial Performance - Net operating revenues for Q3 2025 reached $1,477.5 million, a 9.3% increase from $1,351.0 million in Q3 2024[16] - Total operating expenses for Q3 2025 were $1,233.9 million, up from $1,141.9 million in Q3 2024, reflecting an increase of 8.0%[16] - Net income attributable to Encompass Health for Q3 2025 was $126.5 million, compared to $108.2 million in Q3 2024, representing a 16.0% increase[16] - Earnings per share (EPS) for Q3 2025 was $1.26, up from $1.09 in Q3 2024, indicating a 15.6% growth[16] - Comprehensive income attributable to Encompass Health for Q3 2025 was $126.7 million, up from $108.2 million in Q3 2024[18] - For the three months ended September 30, 2025, net income was $172.7 million, compared to $145.9 million for the same period in 2024, representing an increase of 18.5%[23] - Net income for the nine months ended September 30, 2025, was $556.0 million, an increase from $432.4 million in 2024, representing a growth of 28.5%[28] - Adjusted EBITDA for Q3 2025 was $300.1 million, up from $269.3 million in Q3 2024, reflecting a 11.5% growth[81] - Adjusted EBITDA for the nine months ended September 30, 2025, was $932.3 million, an increase of 14.5% from $814.1 million in the same period of 2024[150] Assets and Liabilities - Total assets as of September 30, 2025, were $6,865.7 million, an increase from $6,534.7 million as of December 31, 2024[20] - Current liabilities decreased to $762.0 million as of September 30, 2025, down from $841.0 million at the end of 2024[20] - Encompass Health's shareholders' equity increased to $2,373.8 million as of September 30, 2025, compared to $2,067.0 million at the end of 2024[20] - The total shareholders' equity at the end of September 2025 was $3,131.9 million, up from $2,669.1 million at the end of September 2024, reflecting a growth of 17.3%[25] - Long-term debt, net of current portion, stood at $2,393.9 million as of September 30, 2025, compared to $2,359.2 million at the end of 2024[60] - Total current liabilities as of September 30, 2025, were $577.3 million, down from $677.3 million as of December 31, 2024[144] - Long-term debt, net of current portion, was $2,328.8 million as of September 30, 2025, compared to $2,273.3 million as of December 31, 2024[144] Cash Flow and Capital Expenditures - Net cash provided by operating activities increased to $829.6 million in 2025 from $724.0 million in 2024, reflecting a rise of 14.6%[28] - The company made capital expenditures of approximately $507 million during the nine months ended September 30, 2025, and expects to spend between $785 million and $820 million for capital expenditures in 2025[137] - The company expects to fund capital expenditures using cash on hand and borrowings under its revolving credit facility[137] Shareholder Returns - Dividends declared for the nine months ended September 30, 2025, were $54.0 million, with a per-share dividend of $0.53, compared to $47.8 million for the same period in 2024[25] - The company repurchased $81.7 million worth of common stock in the open market during the nine months ended September 30, 2025[25] - The company repurchased a total of 221,894 shares of its common stock during the three months ended September 30, 2025, at an average price of $112.69 per share[161] - The maximum number of shares that may yet be purchased under the repurchase plans is approximately $408.5 million[161] Operational Highlights - The company operated 170 inpatient rehabilitation hospitals as of September 30, 2025, with a significant concentration in Florida and Texas[33] - The company expanded its capacity by adding 140 new beds across existing hospitals and new facilities in 2025[89] - The company plans to open new hospitals in St. Petersburg, Amarillo, and Lake Worth by Q4 2025, each with 50 new beds[90] - Discharges increased by 5.0% to 65,839 in Q3 2025, with same-store discharges growing by 2.9%[110] - Net patient revenue per discharge grew by 3.3% to $21,679 in Q3 2025, primarily due to increased reimbursement rates[110] Regulatory and Market Environment - The healthcare industry faces ongoing regulatory challenges, with the One Big Beautiful Bill Act expected to impact Medicaid programs starting in 2027[96] - The company is facing challenges in maintaining hospital volumes due to competition and regulatory burdens, which may impact future growth[101] - The company has engaged with the Medicare Administrative Contractor and CMS to address inconsistencies in the review process affecting claim validation rates[99] - The company expects a net increase of approximately 2.9% in Medicare payment rates effective October 1, 2025, due to the 2026 Final IRF Rule[97] - Medicare accounted for 64.1% of total net operating revenues for the three months ended September 30, 2025, down from 65.4% in the same period of 2024[102] Miscellaneous - The company reported a loss from discontinued operations of $0.4 million in Q3 2025, compared to a loss of $0.7 million in Q3 2024[16] - The company did not record any impairment charges related to its available-for-sale debt securities during the three and nine months ended September 30, 2025[57] - There were no changes in internal control over financial reporting that had a material effect during the quarter ended September 30, 2025[155] - The company continues to face regulatory and legal challenges in the healthcare industry, which may impact its financial position and operations[157]

Group 1 - The article does not provide any specific content related to a company or industry [1]